D

DiaKine Therapeutics

500 employees

DiaKine Therapeutics is a development stage company commercializing novel immune modulators for the treatment of diabetes.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pharmaceutical
Biopharma

Date founded

2004

Funding rounds raised

D

DiaKine Therapeutics raised undisclosed on September 3, 2008

Investors: BlueTree Allied Angels

FAQ